General
Abiraterone acetate shows potential for prostate cancer patients with poor response to ADT | News for Doctor, Nurse, Pharmacist | Pharmacy | MIMS Malaysia
 

Abiraterone acetate shows potential for prostate cancer patients with poor response to ADT | News for Doctor, Nurse, Pharmacist | Pharmacy | MIMS Malaysia

Shared by:

 
Abiraterone acetate shows potential for prostate cancer patients with poor response to ADT | MIMS Malaysia
 
specialty.mims.com
 
24 Apr 2017 - General